OrbiMed
MID Labs lands $51m for eye surgery devices
MID Labs Ltd. said today that it raised a $51 million funding round for its eye surgery devices it plans to use to expand in the U.S. and China.
The round, led by OrbiMed and Frontline BioVentures, also included Softbank China Venture Capital, Allen Chao and Sungent BioVenture, according to a press release.
Acid reflux: Medigus raises $11M from U.S. and Israeli groups
HistoSonics pulls in $14M | Medtech funding for the week of May 19, 2014
Israel-based Keystone Heart raises $14M for cerebral protection
Israeli device maker Keystone Heart raised $14 million in a Series B funding round in support of its TriGaurd implant, designed to help protect the brain during transcatheter valve replacement procedures.
Medrobotics raises $26 million in a Series E fundraising round for Flex surgical robot | Medtech funding stories for the week of May 12, 2014
Inspire Medical raises $40M on launch of new sleep apnea implant
Minnesota-based Inspire Medical raised $40 million in a Series E financing round that the company timed to coincide the launch of its sleep apnea implant.
Unilife raises $60M through debt financing, shares soar
Breast implant maker GC Aesthetics reels in $60M
GC Aesthetics brought $60 million from 3 healthcare investment groups it plans to use to expand its breast implant business.
Dublin-based GC Aesthetics is the umbrella company for 2 different brands, Nagor and Eurosilicone.The funding round was led by a $40 million contribution from OrbiMed, with existing backers Montreux Equity Partners and Oyster Capital contributing the rest.
OrbiMed launches $735M fund
OrbiMed said it launched a new, $735 million fund to back life science companies.
The new fund is slated for investment in all sectors of the healthcare industry, with a focus on North American and European biopharmaceutical, medical device, and diagnostics companies, according to a press release.
The fund is expected to go into roughly 30 companies in slices of $10 million to $50 million apiece, according to the release.
OrbiMed healthcare investment fund raises $160M
New York-based private equity player OrbiMed Advisors raised $160 million for its Healthcare Fund Management division, according to regulatory filings submitted this month.
